Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Predictors of mortality in patients diagnosed with probable Alzheimer's disease.

Bowen JD, Malter AD, Sheppard L, Kukull WA, McCormick WC, Teri L, Larson EB.

Neurology. 1996 Aug;47(2):433-9.

PMID:
8757016
2.

Survival after initial diagnosis of Alzheimer disease.

Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA.

Ann Intern Med. 2004 Apr 6;140(7):501-9.

PMID:
15068977
3.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
4.

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.

Ag├╝ero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B.

J Am Geriatr Soc. 1998 Apr;46(4):444-52.

PMID:
9560066
5.

Clinical outcomes of possible versus probable Alzheimer's disease.

Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC.

Neurology. 2003 Sep 9;61(5):661-7.

PMID:
12963758
6.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
7.

Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study.

Geerlings MI, Deeg DJ, Schmand B, Lindeboom J, Jonker C.

Neurology. 1997 Sep;49(3):798-802.

PMID:
9305343
8.

Extrapyramidal signs in patients with probable Alzheimer disease.

Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1997 Aug;54(8):969-75.

PMID:
9267971
9.

Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.

Tilvis RS, Strandberg TE, Juva K.

J Am Geriatr Soc. 1998 Jun;46(6):712-5.

PMID:
9625186
10.

Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.

Suh GH, Kil Yeon B, Shah A, Lee JY.

Int J Geriatr Psychiatry. 2005 Jan;20(1):26-34.

PMID:
15578675
11.

Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study.

Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y.

Int J Geriatr Psychiatry. 2001 Aug;16(8):810-5.

PMID:
11536348
14.
15.

Alzheimer's disease symptom severity in blacks and whites.

Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L.

J Am Geriatr Soc. 1999 Apr;47(4):482-6.

PMID:
10203126
16.

Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California.

Moritz DJ, Fox PJ, Luscombe FA, Kraemer HC.

Arch Neurol. 1997 Jul;54(7):878-85.

PMID:
9236577
17.

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

Bracco L, Gallato R, Grigoletto F, Lippi A, Lepore V, Bino G, Lazzaro MP, Carella F, Piccolo T, Pozzilli C, et al.

Arch Neurol. 1994 Dec;51(12):1213-9.

PMID:
7986176
18.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
19.
20.

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.

PMID:
9595967

Supplemental Content

Support Center